Tesamorelin Legal Status: Approval, Research Use, and Regulatory Notes
FDA approved (Egrifta). Prescription required. Schedule: Not a controlled substance.
Direct Answer
Tesamorelin is FDA-approved for HIV-related lipodystrophy and has the strongest human evidence of any GHRH analog in this library - multiple Phase 3 RCTs demonstrating significant visceral fat reduction. Outside its approved indication, human data is limited. For research into GHRH-pathway GH stimulation, tesamorelin provides the reference standard with actual regulatory approval behind it.
- Evidence grade
- Level A
- Research status
- FDA Approved
- Category
- Growth Hormone
- Best for
- HIV-associated lipodystrophy, visceral fat reduction, GHRH-mediated GH research
Legal and Regulatory Status
FDA approved (Egrifta). Prescription required. Schedule: Not a controlled substance.
Approval Stage
Tesamorelin is listed as FDA Approved. Approved uses, if any, are indication-specific and do not automatically apply to other claims.
Compliance Notes
- Contraindicated in patients with active malignancy
- Disruption of the hypothalamic-pituitary axis from hypophysectomy, hypopituitarism, or pituitary tumor surgery
- Known hypersensitivity to tesamorelin or mannitol
- Should not be used during pregnancy
- May cause fluid retention and glucose intolerance
Evidence Page
For the complete evidence review, see the main Tesamorelin guide linked below.
Evidence Snapshot
| Evidence grade | Level A |
|---|---|
| Research status | FDA Approved |
| Best supported outcomes | Visceral Adipose Tissue Reduction (Level A), IGF-1 Increase (Level A), and Cognitive Function (Level B) |
| Primary citation count | 3 |
| Last reviewed | 2026-06-02 |
Related Guides
How to Cite This Page
ExaminePeptides. "Tesamorelin Legal Status: Approval, Research Use, and Regulatory Notes." Last reviewed 2026-06-02. https://examinepeptides.com/answers/tesamorelin-legal-status/
This static answer page is built for fast indexing and direct citation. It summarizes the matching full evidence review and links back to primary sources where the source database includes them.